SB
PVCT

Sunflower Bank’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Sunflower Bank’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,411,871
Closed -$163K – 202
2022
Q1 		$163K Hold
2,411,871
– – 0.02% 201
2021
Q4 		$133K Buy
+2,411,871
New +$133K 0.02% 201

Other funds holding PVCT

HFBOT
Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
ACM
Academy Capital Management Waco, Texas $699M AUM 12.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Sunflower Bank's PVCT Position: Q2 2022 in Review

Sunflower Bank sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q2 2022, closing a stake of 2,411,871 shares — an estimated $163K sold.

Sunflower Bank first reported a position in PVCT in Q4 2021 and held it in 2 quarters. The position peaked at $163K in Q1 2022. 7 funds tracked by Wall St. Rank hold PVCT as of Q2 2022.

  • Sunflower Bank reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q2 2022 after selling out during the quarter.
  • Sunflower Bank sold 2,411,871 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q2 2022, an estimated $163K.
  • Sunflower Bank first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q4 2021 and held it in 2 quarters.
  • Sunflower Bank's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $163K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q2 2022.

Based on Sunflower Bank's 13F filing for Q2 2022, filed 13 Sep 2022.